NeuroSync Medical Division
The Medical Division develops tissue regeneration technologies, military medical systems, and clinical decision platforms. The RAPID Family addresses tissue loss from sargassum-derived bioactive compounds. SENTINEL platform protects against CBRN threats. RAPIDHealth accelerates clinical trials through standardized measurement. From battlefield trauma to civilian healthcare — precision medicine meets operational reality.
Medical Division operates two core technology platforms — RAPIDHealth for accelerated clinical development and SENTINEL for defence applications. Both platforms share the NTL-004 software architecture while addressing distinct operational requirements.
Clinical trials acceleration · Regenerative medicine
Standardized measurement and analysis platform for tissue regeneration clinical trials. Enables RAPID Family products — RAPIDSkin, RAPIDBone, RAPIDNeural, RAPIDOncology — to progress through regulatory approval faster through consistent data capture and reporting. Addresses the reproducibility crisis in regenerative medicine research.
RAPIDHealth platformCBRN defence · Military medical · Donor coordination
Military-grade platform for CBRN threat detection, battlefield medical decision support, and donor coordination through SDICS (SoldierNet Donor Identification and Coordination System). Integrates with existing military medical infrastructure while providing advanced predictive capabilities for mass casualty scenarios.
SENTINEL platformThe RAPID Family addresses tissue loss across multiple medical specialties through sargassum-derived bioactive compounds. Each product targets specific tissue types while sharing the same foundational cold-process extraction methodology from Marine Division Bio-Farm operations.
GB2607398.1
Dermal Scaffold
Lyophilised dermal regeneration scaffold for complex wound closure, burn treatment, and surgical reconstruction. Promotes natural tissue regrowth while providing immediate structural support.
Product DetailsGB2607402.1
Osseous Scaffold
Osseous regeneration scaffold for bone defect repair, fracture healing, and orthopaedic reconstruction. Supports natural bone formation while gradually integrating with existing tissue.
Product DetailsGB2607492.2
Neural Repair
Peripheral nerve repair and remyelination treatment for traumatic nerve injury, surgical damage, and degenerative conditions. Accelerates functional recovery through targeted regeneration.
Product DetailsGB2607531.7
Cancer Treatment
Five simultaneous anti-cancer mechanisms targeting tumour growth, metastasis, and treatment resistance. Combines direct cytotoxic effects with immune system enhancement.
Product DetailsGB2607136.5
Haemostatic
Advanced haemostatic wound packing for traumatic bleeding control. Provides rapid blood clotting while delivering bioactive compounds that promote healing and reduce infection risk.
Product DetailsIn Development
Multi-Tissue
Integrated multi-tissue reconstruction system combining skin, bone, and neural regeneration capabilities for complex trauma cases requiring coordinated tissue repair across multiple systems.
Development StatusBATTLEFIELD TRAUMA.
CIVILIAN EMERGENCY.
ONE SYSTEM.
Medical Division defence applications address acute medical scenarios where rapid decision-making determines survival outcomes. SENTINEL platform provides CBRN threat detection, mass casualty coordination, and battlefield medical decision support.
All defence partnerships and military applications are coordinated exclusively through NeuroSync Technologies Limited. SENTINEL platform integrates with existing military medical infrastructure while providing advanced predictive capabilities for mass casualty scenarios.
SENTINEL Applications
CBRN + MEDICAL
Dual-capability platform addressing chemical, biological, radiological, and nuclear threats alongside conventional medical emergency coordination through integrated SDICS methodology.
CBRN threat detection and contamination mapping for operational units
Mass casualty event coordination through SDICS donor information synchronisation
Battlefield medical decision support for Combat Life Savers and field medics
Integration with existing military medical infrastructure and communication systems
Civilian emergency services compatibility for dual-use scenarios
Medical Division follows accelerated development pathways for both civilian and military applications. RAPID Family products progress through clinical trials while SENTINEL platform undergoes military validation through established defence contacts.
Regulatory strategy balances speed with safety — leveraging existing precedents in regenerative medicine while establishing new standards for sargassum-derived bioactive compounds. Military applications benefit from streamlined procurement processes through established MOD relationships.
2026
Patent Protection
Core IP portfolio filed — RAPID Family products, SENTINEL platform, and foundational cold-process extraction methodology.
2027
Clinical Trials
Phase I trials for RAPIDSkin and RAPIDBone. SENTINEL platform military validation through 16 Medical Regiment pathway.
2028
Regulatory Approval
MHRA approval for first RAPID Family products. SENTINEL platform operational deployment through MOD procurement.
2029
Commercial Launch
Full commercial availability for civilian healthcare. International military exports through established defence partnerships.
Medical Division IP portfolio protects core technologies across tissue regeneration, defence systems, and clinical platforms. Filed patents cover both specific applications and foundational methodologies.
GB2606416.2
Foundational patent covering sargassum interception system and integration with medical product extraction. Enables RAPID Family production through Marine Division feedstock.
Filed March 2026
GB2609908.5
Integrated extraction cascade methodology that preserves bioactive compounds while enabling pharmaceutical-grade purification. Foundational to RAPIDHealth platform development.
Filed April 2026
NTL-004 Platform
Multi-vertical software architecture covering ThemeEngine, TerminologyMapper, and FeatureFlags systems. Enables both RAPIDHealth and SENTINEL platform capabilities.
Filing Strategy Pending
SDICS Methodology
Synchronised Donor Information Coordination System covering civilian and military applications. Critical component of SENTINEL platform emergency response capabilities.
Filing Strategy TBD
07 · Contact
Medical Division seeks clinical research partnerships, military procurement contacts, and regulatory development collaborations. For qualified partnerships including clinical trials, defence applications, and healthcare innovation programmes.